The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4
Open accessAbstract
Metastasis of cancer cells is a complex process involving multiple steps including invasion, angiogenesis, and trafficking of cancer cells through blood vessels, extravasations, organ-specific homing, and growth. While matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines play a major role in invasion and angiogenesis, chemokines such as stromal derived factor-1alpha (SDF-1alpha) and their receptors such as CXCR4 are thought to play a critical role in motility, homing, and proliferation of cancer cells at specific metastatic sites. We and others have previously reported that the extracellular signal-activated transcription factor NF-kappaB up-regulates the expression of matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines in highly metastatic breast cancer cell lines. In this report, we demonstrate that NF-kappaB regulates the motility of breast cancer cells by directly up-regulating the expression of CXCR4. Overexpression of the inhibitor of kappaB (IkappaB) in breast cancer cells with constitutive NF-kappaB activity resulted in reduced expression of CXCR4 and a corresponding loss of SDF-1alpha-mediated migration in vitro. Introduction of CXCR4 cDNA into IkappaB-expressing cells restored SDF-1alpha-mediated migration. Electrophoretic mobility shift assays and transient transfection assays revealed that the NF-kappaB subunits p65 and p50 bind directly to sequences within the -66 to +7 region of the CXCR4 promoter and activate transcription. We also show that the cell surface expression of CXCR4 and the SDF-1alpha-mediated migration are enhanced in breast cancer cells isolated from mammary fat pad xenografts compared with parental cells grown in culture. A further increase in CXCR4 cell surface expression and SDF-1alpha-mediated migration was observed with cancer cells that metastasized to the lungs. Taken together, these results implicate NF-kappaB in the migration and the organ-specific homing of metastatic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMD231 cells were obtained from Dr. Harikrishna Nakshatri in 2009 and are a derivative of the MDA-MB-231 cell line (19).”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,582
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat‐Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 818
Self-citationBargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 757
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Sato, H., & Seiki, M. (1993) · PubMed · Cited by 695
Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W., & Groopman, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23169 · Cited by 614
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 476
Cogswell, P. C., D, D. C. G., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452
Bachelder, R. E., Wendt, M. A., & Mercurio, A. M. (2002) · PubMed · Cited by 428
Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., et al. (2000) · PubMed · Cited by 427
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformationPreprint
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin, A. S., Jr. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 401
Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · PubMed · Cited by 386
Development of the Proteasome Inhibitor PS-341
Adams, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-9 · Cited by 376
Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5617 · Cited by 356
Biswas, D. K., Cruz, A. P., Gansberger, E., & Pardee, A. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8542 · Cited by 353
Murakami, T., Maki, W. C., Cardones, A. R., Fang, H., Tun-Kyi, A., Nestle, F. O., & Hwang, S. T. (2002) · PubMed · Cited by 347
Patel, N. M., Nozaki, S., Shortle, N. H., Bhat‐Nakshatri, P., Newton, T. R., Rice, S. E., Gelfanov, V. M., Boswell, S. H., Goulet, R. J., Sledge, G. W., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203768 · Cited by 294
Self-citationKijowski, J., Baj‐Krzyworzeka, M., Majka, M., Reca, R., Marquez‐Curtis, L. A., Christofidou‐Solomidou, M., Janowska‐Wieczorek, A., & Ratajczak, M. Z. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-453 · Cited by 224
An attractive force in metastasis
Liotta, L. A. (2001) · Nature · doi:10.1038/35065180 · Cited by 188
Inhibition of NF-κB Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer Cells
Shibata, A., Nagaya, T., Imai, T., Funahashi, H., Nakao, A., & Seo, H. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015872531675 · Cited by 168
Hansen, S. K., Nerlov, C., Zabel, U., Verde, P., Johnsen, M., Baeuerle, P. A., & Blasi, F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05043.x · Cited by 164
Dong, G., Chen, Z., Kato, T., & Waes, C. V. (1999) · PubMed · Cited by 150
Andela, V. B., Schwarz, E. M., Puzas, J. E., O’Keefe, R. J., & Rosier, R. N. (2000) · PubMed · Cited by 149
Lee, Y., Gotoh, A., Kwon, H., You, M., Kohli, L. L., Mantel, C., Cooper, S. H., Hangoc, G., Miyazawa, K., Ohyashiki, K., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4307 · Cited by 147
Self-citationShattuck-Brandt, R. L., & Richmond, A. (1997) · PubMed · Cited by 142
Edwards, D. R., & Murphy, G. (1998) · Nature · doi:10.1038/28961 · Cited by 140
The role of chemoattraction in cancer metastases
Moore, M. A. S. (2001) · BioEssays · doi:10.1002/bies.1095 · Cited by 138
Slíva, D., Rizzo, M. T., & English, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109579200 · Cited by 134
Nicolson, G. L. (1993) · Cancer and Metastasis Reviews · doi:10.1007/bf00665961 · Cited by 130
Bhat‐Nakshatri, P., Sweeney, C. J., & Nakshatri, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205243 · Cited by 117
Self-citationGenomic organization and promoter characterization of human CXCR4 gene1
Carúz, A., Samsom, M., Alonso, J. M., Alcamı́, J., Baleux, F., Virelizier, J. L., Parmentier, M., & Arenzana‐Seisdedos, F. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00359-7 · Cited by 116
Bhat‐Nakshatri, P., Newton, T. R., Goulet, R. J., & Nakshatri, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6971 · Cited by 90
Self-citationNozaki, S., Sledge, G. W., & Nakshatri, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3241 · Cited by 79
Self-citationNakshatri, H., & Goulet, R. J. (2002) · Current Problems in Cancer · doi:10.1067/mcn.2002.129977 · Cited by 68
Self-citationNewton, T. R., Patel, N. M., Bhat‐Nakshatri, P., Stauss, C. R., Goulet, R. J., & Nakshatri, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18827 · Cited by 64
Self-citationMolecular characterization of CXCR–4: A potential brain tumor-associated gene
Sehgal, A., Ricks, S., Boynton, A. L., Warrick, J., & Murphy, G. P. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199812)69:4 · Cited by 64
Vinante, F., Rigo, A., Scupoli, M. T., & Pizzolo, G. (2002) · Blood · doi:10.1182/blood.v99.1.52 · Cited by 25
Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration
Christopherson, K. W., Campbell, J. J., & Hromas, R. (2001) · Blood · doi:10.1182/blood.v98.13.3562 · Cited by 23
Self-citation
Research works printed but not linked: 8
- Sato, 1993, Oncogene, 8, 395
- Andela, 2000, Cancer Res., 60, 6557
- Dong, 1999, Cancer Res., 59, 3495
- Shattuck-Brandt, 1997, Cancer Res., 57, 3032
- Bachelder, 2002, Cancer Res., 62, 7203
- Koshiba, 2000, Clin. Cancer Res., 6, 3530
- Murakami, 2002, Cancer Res., 62, 7328
- Scotton, 2002, Cancer Res., 62, 5930
Cited by
Sorted by citations
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.49 · Cited by 2,251
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,586
Tumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Metadata
- Authors
- Helbig, G., Christopherson, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., & Nakshatri, H.
- Affiliations
- Indiana University Indianapolis (US)
- Walther Cancer Foundation (US)
- Corresponding author
- Nakshatri, Harikrishna
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 24
- Pages
- 21631-21638
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1980790180
- Cited by
- 639
- References
- 42
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 12 · 2022: 19 · 2021: 14 · 2020: 23 · 2019: 18 · 2018: 33 · 2017: 28 · 2016: 34 · 2015: 30 · 2014: 35 · 2013: 42 · 2012: 18
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health (5r21ca082208-02)
- National Heart, Lung, and Blood Institute (HL67384, R01HL067384)
- National Cancer Institute (CA82208)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK053674, DK53674, T32DK007519)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- NF-κB, breast cancer, metastasis, cell migration, CXCR4, chemokine receptors, SDF-1α, chemokine signaling, IκB, transcriptional regulation, lung metastasis
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Chemotaxis, Flow Cytometry, Genetic Vectors, Humans, Neoplasm Metastasis, Neoplasm Transplantation, Plasmids, Promoter Regions, Genetic, Ribonucleases, RNA, Messenger, Transcription, Genetic, Transfection, Tumor Cells, Cultured, Up-Regulation, Gene Expression Regulation, Neoplastic, NF-kappa B, DNA, Complementary, COS Cells, Receptors, CXCR4, Matrix Metalloproteinases, Mitogen-Activated Protein Kinases, Transcription Factor RelA, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
